Thomas Catinazzo - Jun 27, 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Thomas Catinazzo
Stock symbol
RLAY
Transactions as of
Jun 27, 2024
Transactions value $
-$58,493
Form type
4
Date filed
7/1/2024, 04:41 PM
Previous filing
Apr 29, 2024
Next filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$1.85K -295 -0.09% $6.26 340K Jun 27, 2024 Direct F1, F2
transaction RLAY Common Stock Sale -$56.6K -9.08K -2.67% $6.24 330K Jun 27, 2024 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 304,929 shares underlying RSUs.
F3 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
F4 This transaction was executed in multiple trades at prices ranging from $6.12 to $6.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.